Search Results - "Jo, Norihide"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling by Jo, Norihide, Sogabe, Yuko, Yamada, Yosuke, Ukai, Tomoyo, Kagawa, Harunobu, Mitsunaga, Kanae, Woltjen, Knut, Yamada, Yasuhiro

    Published in Cancer science (01-03-2019)
    “…The emergence of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology has dramatically advanced how we manipulate the genome…”
    Get full text
    Journal Article
  2. 2

    Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells by Sakakura, Megumi, Ohta, Sho, Yagi, Masaki, Tanaka, Akito, Norihide, Jo, Woltjen, Knut, Yamamoto, Takuya, Yamada, Yasuhiro

    “…ES cell (ESC) identity is stably maintained through the coordinated regulation of transcription factors and chromatin structure. SMARCB1, also known as INI1,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals by Jo, Norihide, Zhang, Rui, Ueno, Hideki, Yamamoto, Takuya, Weiskopf, Daniela, Nagao, Miki, Yamanaka, Shinya, Hamazaki, Yoko

    Published in Frontiers in aging (2021)
    “…Age is a major risk factor for COVID-19 severity, and T cells play a central role in anti-SARS-CoV-2 immunity. Because SARS-CoV-2-cross-reactive T cells have…”
    Get full text
    Journal Article
  6. 6

    Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination by Jo, Norihide, Hidaka, Yu, Kikuchi, Osamu, Fukahori, Masaru, Sawada, Takeshi, Aoki, Masahiko, Yamamoto, Masaki, Nagao, Miki, Morita, Satoshi, Nakajima, Takako E, Muto, Manabu, Hamazaki, Yoko

    Published in The Journal of immunology (1950) (01-05-2023)
    “…While the newly developed COVID-19 mRNA vaccines are highly effective, characteristics of the immune response after the vaccination and its association with…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Impaired CD4 + T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination by Jo, Norihide, Hidaka, Yu, Kikuchi, Osamu, Fukahori, Masaru, Sawada, Takeshi, Aoki, Masahiko, Yamamoto, Masaki, Nagao, Miki, Morita, Satoshi, Nakajima, Takako E, Muto, Manabu, Hamazaki, Yoko

    Published in Nature aging (01-01-2023)
    “…Whether age-associated defects in T cells impact the immunogenicity and reactogenicity of mRNA vaccines remains unclear. Using a vaccinated cohort (n = 216),…”
    Get full text
    Journal Article
  9. 9
  10. 10

    TB-01 HUMAN IPS CELL-DERIVED BRAIN TUMOR MODEL UNCOVERS THE EMBRYONIC STEM CELL SIGNATURE AS A KEY DRIVER IN ATYPICAL TERATOID/RHABDOID TUMOR by Terada, Yukinori, Jo, Norihide, Arakawa, Yoshiki, Mineharu, Yohei, Yamada, Yasuhiro, Miyamoto, Susumu

    Published in Neuro-oncology advances (16-12-2019)
    “…Atypical teratoid/rhabdoid tumor (AT/RT), which harbors SMARCB1 mutation and exhibits a characteristic histology of rhabdoid cells, has a poor prognosis…”
    Get full text
    Journal Article
  11. 11

    A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy by Kawamata, Toyotaka, Ohno, Nobuhiro, Sato, Kota, Kobayashi, Masayuki, Jo, Norihide, Yuji, Koichiro, Tanosaki, Ryuji, Yamano, Yoshihisa, Tojo, Arinobu, Uchimaru, Kaoru

    Published in SpringerPlus (04-10-2014)
    “…Introduction Adult T-cell leukemia/lymphoma (ATL) responds poorly to conventional chemotherapy, but allogeneic stem cell transplantation (allo-SCT) may improve…”
    Get full text
    Journal Article
  12. 12